Author
Listed:
- Allison N. Grossberg
(Knoebel Institute for Healthy Aging, University of Denver
University of Denver)
- Lilia A. Koza
(Knoebel Institute for Healthy Aging, University of Denver
University of Denver)
- Aurélie Ledreux
(Knoebel Institute for Healthy Aging, University of Denver)
- Chad Prusmack
(Resilience Code)
- Hari Krishnan Krishnamurthy
(Vibrant Sciences LLC)
- Vasanth Jayaraman
(Vibrant Sciences LLC)
- Ann-Charlotte Granholm
(Knoebel Institute for Healthy Aging, University of Denver)
- Daniel A. Linseman
(Knoebel Institute for Healthy Aging, University of Denver
University of Denver
Eleanor Roosevelt Institute, University of Denver)
Abstract
The COVID-19 pandemic affects more than 81 million people worldwide with over 1.7 million deaths. As the population returns to work, it is critical to develop tests that reliably detect SARS-CoV-2-specific antibodies. Here we present results from a multiplex serology test for assessing the antibody responses to COVID-19. In an initial large cohort, this test shows greater than 99% agreement with COVID-19 PCR test. In a second outpatient cohort consisting of adults and children in Colorado, the IgG responses are more robust in positive/symptomatic participants than in positive/asymptomatic participants, the IgM responses in symptomatic participants are transient and largely fall below the detection limit 30 days after symptom onset, and the levels of IgA against SARS-CoV-2 receptor binding domain are significantly increased in participants with moderate-to-severe symptoms compared to those with mild-to-moderate symptoms or asymptomatic individuals. Our results thus provide insight into serology profiling and the immune response to COVID-19.
Suggested Citation
Allison N. Grossberg & Lilia A. Koza & Aurélie Ledreux & Chad Prusmack & Hari Krishnan Krishnamurthy & Vasanth Jayaraman & Ann-Charlotte Granholm & Daniel A. Linseman, 2021.
"A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients,"
Nature Communications, Nature, vol. 12(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-21040-7
DOI: 10.1038/s41467-021-21040-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-21040-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.